Peripheral artery disease (PAD) is a condition in which narrowed arteries reduce blood flow to the limbs. The disease not only causes leg pain, but also triples the risk for heart attack or stroke. And it seems rates of PAD have risen worldwide.

Limbs slowed and weakened by arteries with plaque build-up can benefit from exercise. Sometimes, patients with those problems have no choice but to create their own exercise plans.

With peripheral arterial disease, plaque builds up in arteries, often in the legs. While patients are in danger of losing a limb, restoring blood flow can reduce the need for amputations.

Scheduling surgery for a blocked leg artery? You may be able to do more than you think to ensure your procedure is a success. Simple lifestyle changes prior to an operation appear to lower the risk of complications and reduce the chance of a repeat surgery.

US Food and Drug Administration officials have approved the first medication-coated stent designed to treat peripheral artery disease (PAD), giving patients with blocked thigh arteries another option.

An investigational drug appears to offer significant improvements for patients with peripheral artery disease (PAD), a recent trial found.

Peripheral artery disease (PAD) patients are now more likely to receive lower extremity bypass surgery to open clogged arteries in their legs. Despite the increase, survival rates remain unchanged.

Patients with more severe forms of peripheral artery disease (PAD) generally have fewer treatment options available, and those that are offered aren't always a home run. A trial has found that two types of stents both offer effective treatment.

U.S. Food and Drug Administration officials today approved generic versions of blockbuster blood thinner Plavix ( clopidogrel bisulfate).

Scientists have increasingly been experimenting with therapies tied to a patient's own stem cells, and peripheral artery disease (PAD) is no exception.